InnSight Technology is dedicated to translational research initiatives that will advance diagnostics and evaluation of eye disease. Their primary focus is the development and commercialization of the OcuCheck biosensor, a novel, hand-held, point-of-service device for detecting anterior ophthalmic (eye) injuries. The device is an impedance-based sensor platform that measures target analyte concentration in human tear film for quantitative analysis of diabetic retinopathy in patients.
EnterpriseWorks Tenure: 2015-2020
News & Milestones
InnSight Technology Now
InnSight Technology is now based in Champaign, Illinois.